sc13g

0000950123-10-109439.txt : 20101129 0000950123-10-109439.hdr.sgml : 20101129 20101129172520 ACCESSION NUMBER: 0000950123-10-109439 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20101129 DATE AS OF CHANGE: 20101129 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STEPHENS WARREN A CENTRAL INDEX KEY: 0001187376 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 111 CENTER STREET CITY: LITTLE ROCK STATE: AR ZIP: 72201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VASCULAR SOLUTIONS INC CENTRAL INDEX KEY: 0001030206 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411859679 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-59371 FILM NUMBER: 101219802 BUSINESS ADDRESS: STREET 1: 6464 SYCAMORE COURT NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55369 BUSINESS PHONE: 7636564300 MAIL ADDRESS: STREET 1: 6464 SYCAMORE COURT NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55369 SC 13G 1 d78115sc13g.htm SC 13G sc13g

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. ___)

Vascular Solutions, Inc.

(Name of Issuer)

Common Stock
(Title of Class of Securities)

800677106
(CUSIP Number)

November 19, 2010
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)
þ Rule 13d-1(c)
o Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13G

CUSIP NO. 92231M109


1.	NAME OF REPORTING PERSONS.
	I.R.S. IDENTIFICATION NO’S. OF ABOVE PERSONS (ENTITIES ONLY).

	Warren A. Stephens

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) o

		(b) þ
3.	SEC USE ONLY ________________________________

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Arkansas, USA

Number of Shares Beneficially Owned by Each Reporting Person With:

5.	SOLE VOTING POWER		589,234

6.	SHARED VOTING POWER		605,078

7.	SOLE DISPOSITIVE POWER		589,234

8.	SHARED DISPOSITIVE POWER		605,078

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON		1,194,312

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES		[ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)		7.1	%

12.	TYPE OF REPORTING PERSON		IN

CUSIP NO. 92231M109

Item 1.

	(a)		Name of Issuer: Vascular Solutions, Inc.

	(b)		Address of Issuer’s Principal Executive Offices:

6464 Sycamore Court
Minneapolis, Minnesota 55369

Item 2.

	(a)		Name of Person Filing: Warren A. Stephens

	(b)		Address of Principal Business Office or, if none, Residence

111 Center Street
Little Rock, Arkansas 72201

	(c)		Citizenship: Arkansas, USA

	(d)		Title of Class of Securities: Common Stock, par value $0.01 per share

	(e)		CUSIP Number: 92231M109


Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c),check whether the person filing is a: NA


Item 4.	Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.


(a)	Amount beneficially owned:	1,194,312

(b)	Percent of class:	7.1	%

(c)	Number of shares as to which the person has:

	(i) Sole power to vote or to direct the vote:	589,234
	(ii) Shared power to vote or to direct the vote:	605,078
	(iii) Sole power to dispose or to direct the disposition of:	589,234
	(iv) Shared power to dispose or to direct the disposition of:	605,078

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

The number of shares of Vascular Solutions, Inc. common stock reported as beneficially owned by the reporting person includes shares held in the name of various family trusts as to which reporting person may be deemed to have beneficial ownership.


Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

N/A

Item 8. Identification and Classification of Members of the Group

N/A

Item 9. Notice of Dissolution of Group

N/A

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


	November 29, 2010 Date
	By:	/s/ Todd Ferguson
		Attorney in fact for
		reporting person

EX-99.1 2 d78115exv99w1.htm EX-99.1 exv99w1

Exhibit 1

POWER OF ATTORNEY
for Executing Forms 3, 4 and 5 and
Schedules 13G and 13D

KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints David A. Knight, William B. Keisler and Todd C. Ferguson the undersigned’s true and lawful attorneys-in-fact to:

(1) execute, for and on behalf of the undersigned, any one or more Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities and Exchange Act of 1934, as amended (the “34 Act”), and the rules thereunder; and Schedules 13G and 13D in accordance with Section 13 of The 34 Act and the rules thereunder;

(2) do and perform any and all acts, for and on behalf of the undersigned, that may be necessary or desirable to complete the execution of any such Form 3, 4 or 5 or Schedules 13G and 13D, and the timely filing of such forms and schedules with the United States Securities and Exchange Commission and any other authority; and

(3) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of any such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned, pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.

The undersigned hereby grants to the foregoing attorneys-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as such attorneys-in-fact might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or their substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Sections 13 and 16 of the Securities and Exchange Act of 1934, as amended, or other applicable Securities laws or rules.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 31st day of January, 2002.


/s/ Warren A. Stephens
Signature

Warren A. Stephens
Printed Name